ArticleACS medicinal chemistry letters2018

Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Orally Bioavailable and Brain Penetrant Mutant IDH1 Inhibitors.

Qian Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.